Integrated Biosciences
Redwood City, California, United States · Artificial Intelligence, Biotechnology, Machine Learning · 50 employees
Integrated Biosciences is a biotechnology company specializing in synthetic biology and machine learning to develop advanced therapeutics for age-related diseases. Founded in 2022, the company focuses on innovative drug discovery methods, utilizing AI and synthetic biology to increase efficiency in drug development. Its cutting-edge approach allows for the identification and modulation of biologic
Funding history
- Series seed — $17.2M — Oct 2024
Recent signals
- Jan 27, 2026: Integrated Biosciences Appoints Daniel J. Anderson as Chief Scientific Officer
- Dec 10, 2024: LVMH Recherche partners with Integrated Biosciences for anti-ageing research
- Dec 10, 2024: LVMH Recherche and Integrated Biosciences Announce Strategic Research Partnership
- Oct 03, 2024: Raised $17.2M in Series seed
See plans & pricing → Track Integrated Biosciences’s funding, hiring, and signals — with verified contacts — on Fundz.